Siensmetrica Announces Formation of Advisory Board

🚀 Exciting News! We’re thrilled to announce the formation of our Advisory Board, a diverse team of experts who will guide us in revolutionizing the way medical professionals and researchers assess the trustworthiness of scientific literature.

Our mission is to leverage cutting-edge data analysis and AI to empower healthcare professionals with the tools to identify the most reliable and impactful research quickly. With the expertise of our Advisory Board, we’re one step closer to achieving this vision.

The board brings together a wealth of expertise across critical fields. It includes a renowned PhD in computer science specializing in AI innovation; three accomplished physicians with backgrounds in cardiology, rheumatology, and anesthesiology, who offer diverse clinical insights; a noted medical researcher and assistant professor of microbiology and immunology with a deep understanding of scientific rigor; and a former biopharma executive with decades of leadership experience in advancing medical innovation. This unique blend of expertise ensures that our platform is grounded in both cutting-edge technology and practical, real-world applicability.

This incredible team will help us develop a solution that transforms how healthcare decisions are informed—saving time, improving outcomes, and advancing trust in science.

Siensmetrica Advisory Board

Greg Bolcer, PhD
Mr. Bolcer is a computer scientist and serial entrepreneur who holds multiple patents in the computer and software technology fields. A founder and Chief Technology Officer of multiple high tech firms, the University of California Irvine awarded him the 2004 Lauds and Laurel’s Distinguished Alumnus award. He is also a member of the UCI Information & Computer Sciences Hall of Fame.

Dr. Jeffrey Curtis, MD, MPH
Dr. Curtis is a Professor of Medicine in the Division of Clinical Immunology and Rheumatology at the University of Alabama at Birmingham (UAB). He holds the Harbert-Ball Endowed Professorship in Rheumatology and leads the UAB Pharmacoepidemiology and Pharmacoeconomics Research (PEER) Unit.

Stephen Gurczynski, PhD
Mr. Gurczynski is an Assistant Research Professor of Microbiology and Immunology at the University of Michigan Medical Research Institute. His primary focus is on virology and microbiology. He has 39 publications and 8 NIH grants.

Phillip Levy, MD, MPH
Dr. Levy is a professor of emergency medicine and a leading cardiovascular disease researcher who has overseen more than 110 funded studies from various entities including the CDC, AHA, and NIH, since arriving at Wayne State in 2002. His work has been highly influential with an h-index of 52 and more than 300 published manuscripts and textbook chapters, including senior authorship on numerous guidelines, scientific statements and consensus papers.

Dr. Adam Rubenstein, MD
Dr. Rubenstein is the Director of Anesthesia Services at Henry Ford Health System. He is a clinical anesthesiologist and educator for Henry Ford Health. He is the former Service Chief for the Department of Anesthesiology, Perioperative, and Pain Medicine at Henry Ford Health Jackson.

James Salanty
Mr. Salanty has over 30 years’ experience as a biopharmaceutical professional with a number of leading pharmaceutical firms including TAP pharmaceuticals, Abbott Labs, and AbbVie. During his 10-plus years with Abbvie Vice President of Rheumatology and later its Vice President Immunology Strategy.

Stay tuned for updates as we continue to grow and develop our platform.

###

Media Contact:
Sage Osterfeld
e: sage.osterfeld@siensmetrica.com
t: +1 (760) 593-7243